Cancer Biology & Therapy

期刊全称Cancer Biology & Therapy
期刊缩写Cancer Biol. Ther.
涉及主题生物医学遗传学内科学化学生物化学癌症研究癌症基因细胞生物学细胞凋亡免疫学病理细胞培养肿瘤科外科细胞
期刊介绍

Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.

期刊ISSNprint: 1538-4047
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
4.43.64.8754.7423.6592.8793.3733.294
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量45115886557117118193141141221175193176
被引量35098186989610187111321096094028423877385088978927089298466
h-Index101
自引率0.00%
涉及的研究领域医学-肿瘤学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
2区3区 肿瘤学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
ONCOLOGYSCIEQ181/326

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
ONCOLOGYSCIEQ180/326
期刊主页http://www.tandfonline.com/loi/kcbt20#.V4he8kz9cSQhttps://www.tandfonline.com/kcbt
投稿网址https://www.editorialmanager.com/CBT
出版商Landes Bioscience
出版国家(地区)UNITED STATES
出版语言English
出版周期Monthly
每年出版文章数51
Gold OA文章占比79.27%
原创研究文献占比
(排除综述)
90.16%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1538-4047%5BISSN%5D
平均审稿周期平均2.3月
平均录用比例约50%
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈